These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 18058319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI, Cho SM, Cui JH, Cao QR, Oh E, Lee BJ.
    Int J Pharm; 2013 Oct 15; 455(1-2):31-9. PubMed ID: 23933050
    [Abstract] [Full Text] [Related]

  • 10. Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.
    Dhakal B, Thakur JK, Mahato RK, Rawat I, Rabin DC, Chhetri RR, Shah KP, Adhikari A, Pandey J.
    ScientificWorldJournal; 2022 Oct 15; 2022():9618344. PubMed ID: 35645632
    [Abstract] [Full Text] [Related]

  • 11. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS, Yee P, Sheshala R.
    Acta Pol Pharm; 2016 Oct 15; 73(2):469-78. PubMed ID: 27180440
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S, Aytekin E, Yavuz B, Bozdağ Pehlivan S, Ünlü N.
    Drug Dev Ind Pharm; 2016 Oct 15; 42(6):1008-17. PubMed ID: 26530146
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and in vitrodisintegration test.
    Sutthapitaksakul L, Thanawuth K, Huanbutta K, Sriamornsak P.
    Pharmazie; 2022 Oct 01; 77(10):287-290. PubMed ID: 36273260
    [Abstract] [Full Text] [Related]

  • 19. Formulation design of fast disintegrating tablets using disintegrant blends.
    Shirsand SB, Suresh S, Swamy PV, Para MS, Nagendra Kumar D.
    Indian J Pharm Sci; 2010 Jan 01; 72(1):130-3. PubMed ID: 20582206
    [Abstract] [Full Text] [Related]

  • 20. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, Rojanarata T, Opanasopit P.
    Drug Dev Ind Pharm; 2015 Jun 01; 41(6):1006-16. PubMed ID: 24865111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.